Punch & Associates Investment Management, Inc. 13D and 13G filings for Harvard Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-07 4:06 pm Sale | 2025-03-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Punch & Associates Investment Management, Inc. | 2,559 0.100% | -289,244 (-99.12%) | Filing |
| 2024-02-14 09:00 am Purchase | 2023-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Punch & Associates Investment Management, Inc. | 291,803 6.800% | 15,399 (+5.57%) | Filing |
| 2023-02-13 5:12 pm Purchase | 2022-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Punch & Associates Investment Management, Inc. | 276,404 6.640% | 59,726 (+27.56%) | Filing |
| 2022-02-14 11:02 am Purchase | 2021-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Punch & Associates Investment Management, Inc. | 216,678 5.310% | 216,678 (New Position) | Filing |